Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda.

Mayanja Y, Abaasa A, Namale G, Asiki G, Price MA, Kamali A.

BMC Infect Dis. 2019 Aug 16;19(1):725. doi: 10.1186/s12879-019-4328-1.

2.

Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.

Namale G, Kamacooko O, Bagiire D, Mayanja Y, Abaasa A, Kilembe W, Price M, Ssemwanga D, Lunkuse S, Nanyonjo M, Ssenyonga W, Mayaud P, Newton R, Kaleebu P, Seeley J.

Sex Transm Infect. 2019 Sep;95(6):405-411. doi: 10.1136/sextrans-2018-053854. Epub 2019 Jul 2.

3.

Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.

Abaasa A, Nash S, Mayanja Y, Price M, Fast PE, Kamali A, Kaleebu P, Todd J.

Vaccine. 2019 Apr 3;37(15):2065-2072. doi: 10.1016/j.vaccine.2019.02.072. Epub 2019 Mar 8.

4.

Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.

Kitonsa J, Mayanja Y, Aling E, Kiwanuka J, Namutundu J, Anywaine Z, Ggayi AB, Kibengo F, Kiwanuka N, Kaleebu P.

PLoS One. 2019 Jan 30;14(1):e0210287. doi: 10.1371/journal.pone.0210287. eCollection 2019.

5.

Correction to: 'Test and Treat' Among Women at High Risk for HIV-Infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.

Mayanja Y, Kamacooko O, Bagiire D, Namale G, Kaleebu P, Seeley J.

AIDS Behav. 2018 Mar;22(3):1062. doi: 10.1007/s10461-017-1998-9.

PMID:
29214411
6.

'Test and Treat' Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.

Mayanja Y, Kamacooko O, Bagiire D, Namale G, Kaleebu P, Seeley J.

AIDS Behav. 2018 Mar;22(3):1053-1061. doi: 10.1007/s10461-017-1973-5. Erratum in: AIDS Behav. 2017 Dec 6;:.

7.

Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala.

Mbonye M, Seeley J, Nalugya R, Kiwanuka T, Bagiire D, Mugyenyi M, Namale G, Mayanja Y, Kamali A.

AIDS Care. 2016;28 Suppl 3:33-8. doi: 10.1080/09540121.2016.1164804.

8.

Acceptance of Treatment of Sexually Transmitted Infections for Stable Sexual Partners by Female Sex Workers in Kampala, Uganda.

Mayanja Y, Mukose AD, Nakubulwa S, Omosa-Manyonyi G, Kamali A, Guwatudde D.

PLoS One. 2016 May 12;11(5):e0155383. doi: 10.1371/journal.pone.0155383. eCollection 2016.

9.

High Levels of Persistent Problem Drinking in Women at High Risk for HIV in Kampala, Uganda: A Prospective Cohort Study.

Weiss HA, Vandepitte J, Bukenya JN, Mayanja Y, Nakubulwa S, Kamali A, Seeley J, Grosskurth H.

Int J Environ Res Public Health. 2016 Jan 22;13(2):153. doi: 10.3390/ijerph13020153.

10.

Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment.

Francis SC, Looker C, Vandepitte J, Bukenya J, Mayanja Y, Nakubulwa S, Hughes P, Hayes RJ, Weiss HA, Grosskurth H.

Sex Transm Infect. 2016 Mar;92(2):142-8. doi: 10.1136/sextrans-2015-052160. Epub 2015 Aug 7.

11.

Alcohol use, mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda.

Vandepitte J, Weiss HA, Bukenya J, Nakubulwa S, Mayanja Y, Matovu G, Kyakuwa N, Hughes P, Hayes R, Grosskurth H.

J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):119-26. doi: 10.1097/QAI.0b013e3182777167.

Supplemental Content

Loading ...
Support Center